{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:00:06Z","timestamp":1792807206999,"version":"4.5.0"},"reference-count":25,"publisher":"Edizioni Minerva Medica","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ital J Dermatol Venereol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.23736\/s2784-8671.24.07946-5","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:32:48Z","timestamp":1725895968000},"source":"Crossref","is-referenced-by-count":2,"title":["Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis"],"prefix":"10.23736","volume":"159","author":[{"given":"Martina","family":"MAURELLI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"GIROLOMONI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"GISONDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S2784-8671.24.07946-5_ref001","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14891"},{"key":"10.23736\/S2784-8671.24.07946-5_ref002","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14888"},{"key":"10.23736\/S2784-8671.24.07946-5_ref003","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.13363"},{"key":"10.23736\/S2784-8671.24.07946-5_ref004","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072701"},{"key":"10.23736\/S2784-8671.24.07946-5_ref005","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211002979"},{"key":"10.23736\/S2784-8671.24.07946-5_ref006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019380"},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref007.1","unstructured":"Italian Medicines Agency (AIFA). Riclassificazione del medicinale per uso umano \u00abCibinqo\u00bb, ai sensi dell'articolo 8, comma 10, della legge 24 dicembre 1993, n. 537 (Determina n. 36\/2023)"},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref007.2","unstructured":"2023 [Internet]. Available from: https:\/\/www.gazzettaufficiale.it\/atto\/serie_generale\/caricaDettaglioAtto\/originario?atto.dataPubblicazioneGazzetta=2023-01-27&amp;atto.codiceRedazionale=23A00343&amp;elenco30giorni=true [cited 2024, Jul 16]."},{"key":"10.23736\/S2784-8671.24.07946-5_ref008","unstructured":"Italian Medicines Agency (AIFA). Regime di rimborsabilita' e prezzo, a seguito di nuove indicazioni terapeutiche, del medicinale per uso umano \u00abDupixent\u00bb (Determina n. 115\/2022); 2022 [Internet]. Available from: https:\/\/www.gazzettaufficiale.it\/atto\/serie_generale\/caricaDettaglioAtto\/originario?atto.dataPubblicazioneGazzetta=2022-02-19&amp;atto.codiceRedazionale=22A01099&amp;elenco30giorni=false [cited 2024, Jul 16]."},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref009.1","unstructured":"Italian Medicines Agency (AIFA). Regime di rimborsabilita' e prezzo a seguito di nuove indicazioni terapeutiche e riclassificazione del medicinale per uso umano \u00abDupixent\u00bb, ai sensi dell'art. 8, comma 10, della legge 24 dicembre 1993, n. 537 (Determina n. DG\/1206\/2020)"},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref009.2","unstructured":"2020 [Internet]. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2020\/12\/09\/20A06601\/SG [cited 2024, Jul 16]."},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref010.1","unstructured":"Italian Medicines Agency (AIFA). [Internet]. Rinegoziazione e riclassificazione del medicinale per uso umano \u00abDupixent\u00bb, ai sensi dell'art. 8, comma 10, della legge 24 dicembre 1993, n. 537 (Determina n. DG\/1205\/2020)"},{"key":"#cr-split#-10.23736\/S2784-8671.24.07946-5_ref010.2","unstructured":"2020 [Internet]. Available from: https:\/\/www.gazzettaufficiale.it\/atto\/serie_generale\/caricaDettaglioAtto\/originario?atto.dataPubblicazioneGazzetta=2020-12-09&amp;atto.codiceRedazionale=20A06600&amp;elenco30giorni=false [cited 2024, Jul 16]."},{"key":"10.23736\/S2784-8671.24.07946-5_ref011","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2218504"},{"key":"10.23736\/S2784-8671.24.07946-5_ref012","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050646"},{"key":"10.23736\/S2784-8671.24.07946-5_ref013","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2070428"},{"key":"10.23736\/S2784-8671.24.07946-5_ref014","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.3.249"},{"key":"10.23736\/S2784-8671.24.07946-5_ref015","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2059220"},{"key":"10.23736\/S2784-8671.24.07946-5_ref016","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-023-01293-4"},{"key":"10.23736\/S2784-8671.24.07946-5_ref017","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.108"},{"key":"10.23736\/S2784-8671.24.07946-5_ref018","first-page":"750","article-title":"Economic evaluation of dupilumab for moderate-to-severe atopic dermatitis: a cost-utility analysis","volume":"17","author":"Zimmermann M","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.23736\/S2784-8671.24.07946-5_ref019","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00721-1"},{"key":"10.23736\/S2784-8671.24.07946-5_ref020","doi-asserted-by":"publisher","DOI":"10.33393\/grhta.2024.2728"},{"key":"10.23736\/S2784-8671.24.07946-5_ref021","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15849"},{"key":"10.23736\/S2784-8671.24.07946-5_ref022","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19756"}],"container-title":["Italian Journal of Dermatology and Venereology"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R23Y2024N06A0607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:16:27Z","timestamp":1738581387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R23Y2024N06A0607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.23736\/s2784-8671.24.07946-5","relation":{},"ISSN":["2784-8671","2784-8450"],"issn-type":[{"value":"2784-8671","type":"print"},{"value":"2784-8450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}